Brentuximab Vedotin

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
 bren-TUK-sih-mab veh-DOH-tin

This page contains brief information about brentuximab vedotin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Adcetris
FDA Approved
Yes

FDA Approval for Brentuximab Vedotin

Use in Cancer

Brentuximab vedotin is approved to treat:

Brentuximab vedotin is also being studied in the treatment of other types of lymphoma.

More About Brentuximab Vedotin

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Brentuximab Vedotin - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Targeted Cancer Therapies - Information about the use of this drug to treat cancer.

Clinical Trials Accepting Patients

Find Clinical Trials for Brentuximab Vedotin - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: September 12, 2011
  • Updated: October 23, 2014